WHO ICTRP trial
K-115 phase 3 add-on study with latanoprost
JPRN-jRCT2080221658 · Japan Primary Registries Network (JPRN)
Key facts
| Trial ID | JPRN-jRCT2080221658 |
|---|---|
| Public title | K-115 phase 3 add-on study with latanoprost |
| Scientific title | Phase 3 confirmatory study of K-115 added to latanoprost in patients with primary open-angle glaucoma (POAG) and ocular hypertension (OH) |
| Primary sponsor | Kowa Co., Ltd. |
| Registry | Japan Primary Registries Network (JPRN) |
| Study type | Interventional |
| Phase | 3 |
| Conditions | POAG or OH |
| Interventions | investigational material(s) Generic name etc : K-115 INN of investigational material : Therapeutic category code : 131 Agents for ophthalmic use Dosage and Administration for Investigational material : Instillation, b.i.d. control… |
| Registration date | Nov 29, 2011 |
| Target size | 200 |
| Secondary IDs | JapicCTI-111700 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: